Navigation Links
PTC Therapeutics to Present at European Pediatric Neurology Society Congress
Date:9/18/2013

SOUTH PLAINFIELD, N.J., Sept. 18, 2013 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that two abstracts have been accepted for the 10th European Pediatric Neurology Society Congress (EPNS) in Brussels, Belgium, on September 25-28.

  • Design of a confirmatory phase 3, multicenter, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy;
  • Disease-related symptoms and activities of daily living: a novel survey of patients with nonsense mutation Duchenne muscular dystrophy will be presented on Wednesday, September 25, 2013 at 13:30 in the selected poster presentation PP3: Neuromuscular and Movement

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

In addition, PTC will sponsor a symposium at EPNS titled New perspectives in the management of Duchenne muscular dystrophy on September 25 from 12:30 to 13:30.

About PTC Therapeutics, Inc.
PTC is biopharmaceutical company focused on the discovery and development of orally-administered, proprietary small molecule drugs that target post-transcriptional control processes. While PTC's discovery programs are directed at targets in multiple therapeutic areas, PTC is focusing particularly on the development and commercialization of treatments for orphan and ultra-orphan disorders. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally-discovered pipeline addresses multiple therapeutic areas, including neuromuscular disorders, oncology and infectious diseases. For more information on the company, please v
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  The In Silico Drug Discovery Conference today ... at the conference, which takes place at North Carolina ... 4, 2014. Researchers, students, drug developers, business development professionals, ... KEYNOTE SPEAKERS Ruben ... of Pharmacy Drug Discovery with Three Dimensional ...
(Date:9/17/2014)... JH Technologies announces the grand opening ... JH Technologies, a leader in sales and support of ... partnership with Leica Microsystems into the Southern California market. ... will be featured at the grand opening slated for ... is located within the JH Technologies office’s at 18025 ...
(Date:9/17/2014)... 2014 Hussey Copper , a leader ... antimicrobial copper, announces Gilmour Academy Ice Arena,s conversion of ... antimicrobial solid touch surface to help protect against bacteria.  ... surface that kills greater than 99.9% of MRSA, E-coli ... , Innovative ...
(Date:9/17/2014)... de septiembre de 2014  Cryoport, Inc. ... mundial de soluciones logísticas avanzadas criogénicas para ... vida, anunció hoy la contratación de Broekman ... sede en Rótterdam, Países Bajos, para proporcionar ... en rápido crecimiento. Según los términos del ...
Breaking Biology Technology:In Silico Drug Discovery Conference Announces Speakers and Topics 2In Silico Drug Discovery Conference Announces Speakers and Topics 3In Silico Drug Discovery Conference Announces Speakers and Topics 4In Silico Drug Discovery Conference Announces Speakers and Topics 5In Silico Drug Discovery Conference Announces Speakers and Topics 6In Silico Drug Discovery Conference Announces Speakers and Topics 7JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 2JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 3Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5
... XI,AN, China, Aug. 20 /Xinhua-PRNewswire/ -- Huifeng ... leading developer and,producer of plant extracts and ... and food production, today announced it will,be ... Conference, August 19-21 in Rio,de Janeiro, Brazil., ...
... with Lilly,s Animal Health Division, GREENFIELD, Ind., Aug. ... (NYSE: LLY ), today announced that Lilly has ... dairy cow supplement,Posilac(R) (sometribove), as well as the product,s ... "Global dairy demand is increasing, outstripping supply, and consumers,are ...
... Melissa Patterson, a W. Burghardt Turner Fellow at ... the American Chemical Society,s national meeting in Philadelphia on ... a new instrument at the U.S. Department of Energy,s ... scientists, the instrument enables researchers to make nanoclusters of ...
Cached Biology Technology:Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil 2Elanco Announces Acquisition of Posilac(R) Dairy Business 2Elanco Announces Acquisition of Posilac(R) Dairy Business 3
(Date:9/18/2014)... their entire lives nestling in the protective tentacles of ... they sometimes travel hundreds of kilometres across the open ... fish has been predicted, this is the first time ... populations has been observed. , Dr Steve Simpson, Senior ... University of Exeter, and colleagues from the Australian Research ...
(Date:9/17/2014)... State,s Institute for the Arts and Humanities has received ... for a two-year project, "The Boundaries of the Human ... project will support a wide-ranging series of events aimed ... humanities. One involves artists and researchers who are exploring ... the idea of humanism, and the other involves the ...
(Date:9/17/2014)... 2014) A rare genetic disorder known as Jacobsen syndrome ... joint investigation by researchers at San Diego State University ... to suggesting better treatment options for people with Jacobsen ... genetic underpinnings of autism., Jacobsen syndrome affects approximately 1 ... Health. It occurs in a person when there is ...
Breaking Biology News(10 mins):Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3Mellon Foundation awards grant for major project in the humanities and sciences 2A link between Jacobsen syndrome and autism 2
... DALLAS Jan. 10, 2008 Dr. Beth Levine, chief ... today as one of the states top rising stars in ... Texas (TAMEST). Dr. Levine was named a recipient of ... academy at its annual conference in Houston. Each year, the ...
... the western world, but new therapies based on stem cells ... held back however by the difficulty testing new therapies on ... value owing to differences in structure and activity. The only ... create computerised in-silico models that simulate the real heart and ...
... Sensor Solutions are Expanding eDirectory Applications and, ... Sectors, SUNNYVALE, Calif., Jan. 9 Ingram ... technology distributor, has signed an,agreement with Fujitsu Microelectronics ... interface products for Novell(R) eDirectory(TM),and Novell Access Manager. ...
Cached Biology News:UT Southwestern scientist honored among best in Texas research 2UT Southwestern scientist honored among best in Texas research 3The construction of heart modelling leads path to new therapies 2The construction of heart modelling leads path to new therapies 3Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States 2Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States 3
... all-inclusive collection of key procedures for use ... developed by the leaders in Pichia expression ... book will guide you from choosing the ... analysis, to production of your protein of ...
...
Antibodies were affinity purified using epitopes specific to USP33 immobilized on solid support....
... 30% of IgM-rheumatoid factor paraproteins ... not cross-react with IgM, IgA, or ... with pooled F(Ab)2 fragments. This antibody ... detect rheumatoid factor. Product Category: Hormone ...
Biology Products: